Results. There were 8,677 CHB patients (3.8%) among 226,592 RA patients in the database. The age distribution or gender difference in CHB patients was comparable to the general RA population. Hydroxychloroquine was the most frequently (66.2%) prescribed DMARD. Thirty four percent of CHB patients had been prescribed with methotrexate (MTX) during the study period; most of them without concomitant anti-viral treatment. About 3% of RA patients with CHB were prescribed with TNF inhibitors. Conclusion. Apart from the published expert recommendations, MTX still seems to be one of the main DMARDs prescribed to Korean RA patients with CHB. This is most likely due to the lack of evidence-based, effective treatment strategies for this subgroup of patients.
. Classifying RA patients with chronic hepatitis B. Patients were selected using prescription information, laboratory tests, and ICD-9 code. Patients were pooled (1+2+3+4) for further analysis (*at least 2 incidents, † at least 1 incident of blood test). RA: rheumatoid arthritis, PEG-IFN: pegylated interferon, HBV: hepatitis B virus, AFP: alpha fetoprotein. RA: rheumatoid arthritis, *Prescribed at least twice during study period (Table 4) .
시행에도 불구하고 3% 이상을 상회하고 있다 (2)
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